GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Price-to-Owner-Earnings

Tci Gene (ROCO:6879) Price-to-Owner-Earnings : 287.04 (As of May. 22, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Price-to-Owner-Earnings?

As of today (2024-05-22), Tci Gene's share price is NT$77.50. Tci Gene's Owner Earnings per Share (TTM) ended in Dec. 2023 was NT$0.27. It's Price-to-Owner-Earnings for today is 287.04.


The historical rank and industry rank for Tci Gene's Price-to-Owner-Earnings or its related term are showing as below:

ROCO:6879' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 291.32   Med: 307.17   Max: 334.72
Current: 293.58

During the past 5 years, the highest Price-to-Owner-Earnings of Tci Gene was 334.72. The lowest was 291.32. And the median was 307.17.


ROCO:6879's Price-to-Owner-Earnings is ranked worse than
92.59% of 162 companies
in the Biotechnology industry
Industry Median: 33.52 vs ROCO:6879: 293.58

As of today (2024-05-22), Tci Gene's share price is NT$77.50. Tci Gene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.44. Therefore, Tci Gene's PE Ratio for today is 176.14.

As of today (2024-05-22), Tci Gene's share price is NT$77.50. Tci Gene's EPS without NRI for the trailing twelve months (TTM) ended in was NT$0.44. Therefore, Tci Gene's PE Ratio without NRI for today is 174.94.

During the past 5 years, Tci Gene's highest PE Ratio without NRI was 200.23. The lowest was 25.09. And the median was 32.87.


Tci Gene Price-to-Owner-Earnings Historical Data

The historical data trend for Tci Gene's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Price-to-Owner-Earnings Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - 315.09

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only - - - - 315.09

Competitive Comparison of Tci Gene's Price-to-Owner-Earnings

For the Biotechnology subindustry, Tci Gene's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tci Gene's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Tci Gene's Price-to-Owner-Earnings falls into.



Tci Gene Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Tci Gene's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=77.50/0.27
=287.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tci Gene  (ROCO:6879) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Tci Gene Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Tci Gene's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines